Andrew Bradford
Concepts (333)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrial Neoplasms | 7 | 2021 | 141 | 1.910 |
Why?
| Follicle Stimulating Hormone | 13 | 2023 | 216 | 1.770 |
Why?
| Luteinizing Hormone | 13 | 2022 | 169 | 1.560 |
Why?
| Hyperlipidemias | 3 | 2022 | 122 | 1.070 |
Why?
| Hyperinsulinism | 3 | 2022 | 103 | 1.060 |
Why?
| Leiomyoma | 3 | 2019 | 45 | 1.050 |
Why?
| Uterine Neoplasms | 3 | 2019 | 73 | 1.020 |
Why?
| E2F1 Transcription Factor | 7 | 2023 | 57 | 0.990 |
Why?
| Obesity | 13 | 2023 | 2524 | 0.980 |
Why?
| Protein Kinase C-alpha | 3 | 2009 | 41 | 0.940 |
Why?
| Prolactin | 9 | 2022 | 95 | 0.940 |
Why?
| Pituitary Gland | 7 | 2021 | 148 | 0.870 |
Why?
| Metabolic Syndrome | 3 | 2021 | 324 | 0.850 |
Why?
| Human Growth Hormone | 1 | 2022 | 38 | 0.800 |
Why?
| Gene Expression Profiling | 6 | 2019 | 1523 | 0.800 |
Why?
| Proto-Oncogene Proteins | 9 | 2015 | 609 | 0.770 |
Why?
| Soybean Oil | 1 | 2021 | 12 | 0.760 |
Why?
| Corpus Luteum | 3 | 2016 | 19 | 0.750 |
Why?
| Phospholipids | 2 | 2021 | 199 | 0.700 |
Why?
| Gene Expression Regulation, Neoplastic | 8 | 2021 | 1144 | 0.680 |
Why?
| Protein Kinase C-delta | 4 | 2009 | 70 | 0.670 |
Why?
| Leiomyosarcoma | 1 | 2019 | 26 | 0.670 |
Why?
| Promoter Regions, Genetic | 14 | 2023 | 1133 | 0.630 |
Why?
| Insulin | 5 | 2022 | 2082 | 0.610 |
Why?
| Cell Proliferation | 7 | 2015 | 2191 | 0.580 |
Why?
| Gene Expression Regulation | 11 | 2023 | 2329 | 0.550 |
Why?
| Apoptosis | 10 | 2023 | 2366 | 0.530 |
Why?
| Signal Transduction | 11 | 2021 | 4525 | 0.520 |
Why?
| High Fructose Corn Syrup | 1 | 2015 | 7 | 0.510 |
Why?
| Weight Gain | 2 | 2016 | 451 | 0.510 |
Why?
| Granulosa Cells | 1 | 2015 | 29 | 0.510 |
Why?
| Proto-Oncogene Proteins c-ets | 8 | 2007 | 51 | 0.480 |
Why?
| Fibroblast Growth Factor 2 | 3 | 2006 | 83 | 0.460 |
Why?
| Adenocarcinoma | 3 | 2009 | 795 | 0.450 |
Why?
| Dietary Fats | 1 | 2015 | 290 | 0.440 |
Why?
| Biomarkers, Tumor | 1 | 2019 | 1045 | 0.430 |
Why?
| Transcription Factors | 8 | 2018 | 1531 | 0.430 |
Why?
| DNA-Binding Proteins | 8 | 2018 | 1318 | 0.420 |
Why?
| MicroRNAs | 2 | 2015 | 603 | 0.390 |
Why?
| Cross-Over Studies | 3 | 2022 | 441 | 0.390 |
Why?
| Gonadotropins | 3 | 2023 | 37 | 0.380 |
Why?
| Fibroblast Growth Factors | 3 | 2021 | 162 | 0.380 |
Why?
| Aromatase Inhibitors | 3 | 2020 | 49 | 0.380 |
Why?
| E2F Transcription Factors | 4 | 2023 | 55 | 0.370 |
Why?
| Fibroblast Growth Factor 4 | 3 | 2006 | 19 | 0.360 |
Why?
| Homeodomain Proteins | 5 | 2012 | 464 | 0.360 |
Why?
| Estradiol | 5 | 2023 | 455 | 0.350 |
Why?
| Cell Line, Tumor | 10 | 2021 | 2715 | 0.340 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 144 | 0.320 |
Why?
| Female | 31 | 2023 | 59611 | 0.320 |
Why?
| RNA, Messenger | 2 | 2015 | 2563 | 0.310 |
Why?
| Hydrocortisone | 2 | 2022 | 266 | 0.310 |
Why?
| Ovarian Neoplasms | 1 | 2012 | 386 | 0.290 |
Why?
| Menstrual Cycle | 2 | 2019 | 108 | 0.280 |
Why?
| Growth Hormone | 3 | 2022 | 103 | 0.260 |
Why?
| Genes, Tumor Suppressor | 4 | 2023 | 78 | 0.260 |
Why?
| MAP Kinase Signaling System | 2 | 2006 | 276 | 0.250 |
Why?
| Cell Cycle Proteins | 4 | 2023 | 551 | 0.250 |
Why?
| Humans | 36 | 2023 | 115039 | 0.230 |
Why?
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 107 | 0.220 |
Why?
| rac1 GTP-Binding Protein | 1 | 2003 | 56 | 0.210 |
Why?
| Gonadotropin-Releasing Hormone | 4 | 2021 | 188 | 0.210 |
Why?
| Transcription Factor DP1 | 2 | 2023 | 21 | 0.210 |
Why?
| Pituitary Hormones | 1 | 2022 | 16 | 0.210 |
Why?
| Transcription, Genetic | 3 | 2009 | 1317 | 0.200 |
Why?
| Thyroid Hormones | 1 | 2022 | 53 | 0.200 |
Why?
| Thyrotropin | 1 | 2022 | 99 | 0.200 |
Why?
| Transcription Factor Pit-1 | 6 | 2003 | 24 | 0.200 |
Why?
| Animals | 18 | 2016 | 31867 | 0.200 |
Why?
| Hypothalamus | 2 | 2014 | 147 | 0.200 |
Why?
| Tandem Mass Spectrometry | 2 | 2015 | 413 | 0.200 |
Why?
| Proto-Oncogene Proteins p21(ras) | 3 | 1997 | 228 | 0.190 |
Why?
| Protein Kinase C | 1 | 2003 | 275 | 0.190 |
Why?
| Tumor Cells, Cultured | 4 | 2007 | 851 | 0.190 |
Why?
| Emulsions | 1 | 2021 | 43 | 0.190 |
Why?
| Phosphorylation | 4 | 2009 | 1572 | 0.180 |
Why?
| Leptin | 1 | 2022 | 211 | 0.180 |
Why?
| Heparin | 1 | 2022 | 222 | 0.180 |
Why?
| Lipids | 2 | 2022 | 586 | 0.180 |
Why?
| Rats | 9 | 2006 | 4973 | 0.180 |
Why?
| Thinness | 1 | 2021 | 87 | 0.180 |
Why?
| Adiponectin | 1 | 2022 | 212 | 0.180 |
Why?
| Creatinine | 1 | 2022 | 425 | 0.180 |
Why?
| Fatty Acids, Nonesterified | 1 | 2021 | 151 | 0.180 |
Why?
| Wnt Proteins | 1 | 2021 | 134 | 0.180 |
Why?
| Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2016 | 11 | 0.170 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 157 | 0.170 |
Why?
| Proto-Oncogene Protein c-ets-1 | 6 | 2003 | 18 | 0.170 |
Why?
| Insulin-Like Growth Factor I | 1 | 2022 | 286 | 0.170 |
Why?
| Bcl-2-Like Protein 11 | 2 | 2016 | 37 | 0.170 |
Why?
| Cell Cycle | 2 | 2015 | 544 | 0.170 |
Why?
| Wnt Signaling Pathway | 1 | 2021 | 147 | 0.170 |
Why?
| Chitinase-3-Like Protein 1 | 1 | 2019 | 17 | 0.170 |
Why?
| beta Catenin | 1 | 2021 | 220 | 0.170 |
Why?
| Intramolecular Oxidoreductases | 1 | 2019 | 57 | 0.160 |
Why?
| Eicosapentaenoic Acid | 1 | 2019 | 28 | 0.160 |
Why?
| Docosahexaenoic Acids | 1 | 2019 | 69 | 0.160 |
Why?
| Cytoskeletal Proteins | 1 | 2019 | 145 | 0.160 |
Why?
| Follicular Phase | 2 | 2015 | 36 | 0.160 |
Why?
| Estrogens | 3 | 2019 | 313 | 0.150 |
Why?
| Gene Knockdown Techniques | 2 | 2009 | 299 | 0.150 |
Why?
| Microtubule-Associated Proteins | 1 | 2019 | 174 | 0.150 |
Why?
| Estrone | 2 | 2015 | 35 | 0.150 |
Why?
| Pituitary Gland, Anterior | 1 | 1997 | 39 | 0.150 |
Why?
| Immunoenzyme Techniques | 2 | 2009 | 192 | 0.150 |
Why?
| Etoposide | 2 | 2009 | 148 | 0.150 |
Why?
| Fibroblasts | 3 | 2018 | 839 | 0.140 |
Why?
| Genes, p16 | 1 | 2016 | 17 | 0.140 |
Why?
| Aromatase | 2 | 2014 | 30 | 0.140 |
Why?
| Oncogene Proteins | 1 | 1996 | 53 | 0.140 |
Why?
| RNA-Binding Proteins | 1 | 2019 | 352 | 0.130 |
Why?
| Genes, ras | 2 | 1997 | 91 | 0.130 |
Why?
| Dietary Supplements | 2 | 2019 | 458 | 0.130 |
Why?
| Enzyme Activation | 2 | 2009 | 791 | 0.130 |
Why?
| Adult | 12 | 2021 | 30655 | 0.130 |
Why?
| Blotting, Western | 2 | 2009 | 1149 | 0.130 |
Why?
| Ovulation | 1 | 2015 | 39 | 0.130 |
Why?
| Pregnancy | 3 | 2023 | 5519 | 0.130 |
Why?
| Molecular Sequence Annotation | 1 | 2015 | 81 | 0.130 |
Why?
| Cumulus Cells | 1 | 2015 | 6 | 0.120 |
Why?
| Diagnosis, Differential | 1 | 2019 | 1355 | 0.120 |
Why?
| Sensitivity and Specificity | 1 | 2019 | 1715 | 0.120 |
Why?
| Cytokines | 3 | 2021 | 1843 | 0.120 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 331 | 0.120 |
Why?
| Circadian Rhythm | 1 | 2017 | 354 | 0.120 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2015 | 172 | 0.120 |
Why?
| Tumor Suppressor Protein p14ARF | 1 | 2014 | 6 | 0.120 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2018 | 447 | 0.120 |
Why?
| Fatty Acids, Omega-3 | 1 | 2015 | 124 | 0.120 |
Why?
| Blood Chemical Analysis | 1 | 2015 | 90 | 0.120 |
Why?
| Hormone Antagonists | 1 | 2014 | 33 | 0.120 |
Why?
| Luteal Phase | 1 | 2014 | 41 | 0.110 |
Why?
| Diet, High-Fat | 1 | 2015 | 225 | 0.110 |
Why?
| Transfection | 3 | 2009 | 872 | 0.110 |
Why?
| Repressor Proteins | 1 | 1997 | 368 | 0.110 |
Why?
| Neoplasms, Experimental | 1 | 2014 | 151 | 0.110 |
Why?
| Breast Neoplasms | 3 | 2012 | 1865 | 0.110 |
Why?
| RNA Interference | 2 | 2018 | 437 | 0.110 |
Why?
| Postmenopause | 1 | 2015 | 304 | 0.110 |
Why?
| RNA, Small Interfering | 2 | 2018 | 541 | 0.100 |
Why?
| DNA Fingerprinting | 1 | 2012 | 27 | 0.100 |
Why?
| Base Sequence | 3 | 2012 | 2119 | 0.100 |
Why?
| Cell Line | 5 | 2018 | 2645 | 0.100 |
Why?
| Tumor Suppressor Proteins | 1 | 2014 | 282 | 0.100 |
Why?
| DNA, Complementary | 2 | 2012 | 257 | 0.100 |
Why?
| Weight Loss | 1 | 2016 | 641 | 0.100 |
Why?
| Testosterone | 1 | 2015 | 343 | 0.100 |
Why?
| Neoplasms | 2 | 2023 | 2106 | 0.100 |
Why?
| Pulsatile Flow | 1 | 2011 | 54 | 0.090 |
Why?
| Cell Survival | 2 | 2021 | 1022 | 0.090 |
Why?
| Mutation | 1 | 2021 | 3350 | 0.090 |
Why?
| Adiposity | 1 | 2015 | 466 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 928 | 0.090 |
Why?
| Colony-Forming Units Assay | 1 | 2009 | 89 | 0.090 |
Why?
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 61 | 0.090 |
Why?
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 69 | 0.080 |
Why?
| Transforming Growth Factor beta | 1 | 2012 | 448 | 0.080 |
Why?
| Progesterone | 3 | 2016 | 232 | 0.080 |
Why?
| Models, Biological | 2 | 2016 | 1636 | 0.080 |
Why?
| Luciferases | 1 | 2009 | 142 | 0.080 |
Why?
| Glycogen Synthase Kinase 3 | 1 | 2009 | 78 | 0.080 |
Why?
| Membrane Proteins | 1 | 2015 | 1019 | 0.080 |
Why?
| Cyclin D1 | 1 | 2009 | 61 | 0.080 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 744 | 0.080 |
Why?
| NIH 3T3 Cells | 1 | 2009 | 137 | 0.080 |
Why?
| Mutant Proteins | 1 | 2009 | 95 | 0.080 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 441 | 0.080 |
Why?
| Young Adult | 7 | 2020 | 10498 | 0.080 |
Why?
| Matrix Metalloproteinase 11 | 1 | 2008 | 4 | 0.080 |
Why?
| Neoplastic Stem Cells | 1 | 2012 | 332 | 0.080 |
Why?
| PTEN Phosphohydrolase | 1 | 2009 | 140 | 0.080 |
Why?
| RNA, Neoplasm | 1 | 2008 | 80 | 0.080 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 262 | 0.080 |
Why?
| Myometrium | 1 | 2008 | 35 | 0.080 |
Why?
| Mice, Nude | 1 | 2009 | 631 | 0.080 |
Why?
| Rabbits | 1 | 2009 | 750 | 0.080 |
Why?
| Isoenzymes | 2 | 2003 | 286 | 0.070 |
Why?
| Neoplasm Invasiveness | 1 | 2009 | 442 | 0.070 |
Why?
| DNA, Neoplasm | 1 | 2008 | 157 | 0.070 |
Why?
| Cell Adhesion | 1 | 2009 | 430 | 0.070 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 400 | 0.070 |
Why?
| Active Transport, Cell Nucleus | 1 | 2007 | 110 | 0.070 |
Why?
| DNA Primers | 1 | 2008 | 514 | 0.070 |
Why?
| HeLa Cells | 2 | 2000 | 562 | 0.070 |
Why?
| DNA Damage | 1 | 2009 | 357 | 0.070 |
Why?
| Subcellular Fractions | 1 | 2006 | 78 | 0.070 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2016 | 58 | 0.070 |
Why?
| Proto-Oncogene Proteins c-raf | 2 | 1997 | 43 | 0.070 |
Why?
| Mammary Glands, Human | 1 | 2007 | 60 | 0.070 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2006 | 88 | 0.070 |
Why?
| Immunoprecipitation | 1 | 2006 | 152 | 0.070 |
Why?
| Ultraviolet Rays | 1 | 2009 | 368 | 0.070 |
Why?
| Adolescent | 7 | 2021 | 17862 | 0.070 |
Why?
| Growth Hormone-Releasing Hormone | 1 | 2006 | 27 | 0.070 |
Why?
| raf Kinases | 1 | 2006 | 11 | 0.070 |
Why?
| Protein Kinase Inhibitors | 2 | 2009 | 786 | 0.070 |
Why?
| Prospective Studies | 4 | 2023 | 6232 | 0.070 |
Why?
| Autocrine Communication | 1 | 2006 | 42 | 0.070 |
Why?
| Receptors, Growth Factor | 1 | 2006 | 49 | 0.070 |
Why?
| Mice | 4 | 2012 | 14927 | 0.070 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 172 | 0.070 |
Why?
| Prostate | 1 | 2007 | 157 | 0.070 |
Why?
| Paracrine Communication | 1 | 2006 | 56 | 0.060 |
Why?
| Caspases | 1 | 2006 | 245 | 0.060 |
Why?
| Reproduction | 1 | 2007 | 179 | 0.060 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 181 | 0.060 |
Why?
| Body Mass Index | 3 | 2021 | 1967 | 0.060 |
Why?
| Hypothalamo-Hypophyseal System | 2 | 2017 | 164 | 0.060 |
Why?
| Biomarkers | 1 | 2015 | 3419 | 0.060 |
Why?
| ras Proteins | 1 | 2006 | 138 | 0.060 |
Why?
| Cell Movement | 1 | 2009 | 866 | 0.060 |
Why?
| Cell Nucleus | 1 | 2007 | 556 | 0.060 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2006 | 278 | 0.060 |
Why?
| Oncogene Protein p65(gag-jun) | 1 | 2004 | 2 | 0.060 |
Why?
| Middle Aged | 2 | 2019 | 26827 | 0.060 |
Why?
| Ovulation Induction | 2 | 2015 | 49 | 0.060 |
Why?
| Inflammation | 1 | 2015 | 2485 | 0.060 |
Why?
| Hypogonadism | 2 | 2015 | 75 | 0.060 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2004 | 47 | 0.060 |
Why?
| Thyroid Neoplasms | 1 | 2007 | 263 | 0.060 |
Why?
| Thiocarbamates | 1 | 2003 | 6 | 0.060 |
Why?
| Phospholipid Ethers | 1 | 2003 | 7 | 0.060 |
Why?
| Gene Expression | 2 | 2021 | 1423 | 0.060 |
Why?
| Bridged-Ring Compounds | 1 | 2003 | 9 | 0.060 |
Why?
| Culture Media, Serum-Free | 1 | 2003 | 42 | 0.060 |
Why?
| Thiones | 1 | 2003 | 14 | 0.060 |
Why?
| Norbornanes | 1 | 2003 | 13 | 0.060 |
Why?
| Chromones | 1 | 2003 | 35 | 0.060 |
Why?
| E2F3 Transcription Factor | 1 | 2023 | 8 | 0.060 |
Why?
| Follicle Stimulating Hormone, Human | 1 | 2023 | 11 | 0.060 |
Why?
| Immunohistochemistry | 1 | 2007 | 1634 | 0.050 |
Why?
| Androstadienes | 1 | 2003 | 97 | 0.050 |
Why?
| Morpholines | 1 | 2003 | 101 | 0.050 |
Why?
| Molecular Sequence Data | 4 | 2012 | 2796 | 0.050 |
Why?
| Cluster Analysis | 2 | 2015 | 458 | 0.050 |
Why?
| Models, Molecular | 1 | 2007 | 1379 | 0.050 |
Why?
| Protein Isoforms | 1 | 2003 | 339 | 0.050 |
Why?
| Pituitary Neoplasms | 1 | 2003 | 157 | 0.050 |
Why?
| Aged | 1 | 2019 | 19119 | 0.050 |
Why?
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 29 | 0.050 |
Why?
| Transcription Factor CHOP | 1 | 2021 | 28 | 0.050 |
Why?
| Fat Emulsions, Intravenous | 1 | 2021 | 30 | 0.050 |
Why?
| Indazoles | 1 | 2021 | 58 | 0.050 |
Why?
| Mutagenesis, Site-Directed | 2 | 2004 | 345 | 0.050 |
Why?
| Endoplasmic Reticulum Stress | 1 | 2021 | 91 | 0.040 |
Why?
| Genetic Fitness | 1 | 2021 | 54 | 0.040 |
Why?
| Heat-Shock Proteins | 1 | 2021 | 113 | 0.040 |
Why?
| Glucose Clamp Technique | 1 | 2021 | 181 | 0.040 |
Why?
| Pancreatic Neoplasms | 1 | 2007 | 722 | 0.040 |
Why?
| Imidazoles | 1 | 2021 | 209 | 0.040 |
Why?
| DNA | 2 | 1997 | 1352 | 0.040 |
Why?
| Disease Susceptibility | 1 | 2021 | 316 | 0.040 |
Why?
| Cell Differentiation | 1 | 2006 | 1700 | 0.040 |
Why?
| ADP-Ribosylation Factors | 1 | 2018 | 16 | 0.040 |
Why?
| Progestins | 1 | 2019 | 75 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2021 | 347 | 0.040 |
Why?
| Academic Medical Centers | 1 | 2021 | 412 | 0.040 |
Why?
| Recurrence | 1 | 2021 | 941 | 0.040 |
Why?
| Dimerization | 1 | 2018 | 176 | 0.040 |
Why?
| Pyridines | 1 | 2021 | 425 | 0.040 |
Why?
| Proto-Oncogene Protein c-ets-2 | 1 | 1997 | 3 | 0.040 |
Why?
| Disease Management | 1 | 2021 | 563 | 0.040 |
Why?
| Ectopic Gene Expression | 1 | 2016 | 4 | 0.040 |
Why?
| ets-Domain Protein Elk-1 | 1 | 1996 | 13 | 0.030 |
Why?
| Catalysis | 1 | 1997 | 292 | 0.030 |
Why?
| Retinoblastoma Protein | 1 | 2016 | 52 | 0.030 |
Why?
| Pituitary-Adrenal System | 1 | 2017 | 130 | 0.030 |
Why?
| Transduction, Genetic | 1 | 1996 | 113 | 0.030 |
Why?
| Hormones | 1 | 2016 | 132 | 0.030 |
Why?
| Infertility, Female | 1 | 2016 | 94 | 0.030 |
Why?
| Administration, Cutaneous | 1 | 2015 | 117 | 0.030 |
Why?
| Oocyte Retrieval | 1 | 2015 | 11 | 0.030 |
Why?
| Limit of Detection | 1 | 2015 | 53 | 0.030 |
Why?
| Phosphoprotein Phosphatases | 1 | 2015 | 64 | 0.030 |
Why?
| Neovascularization, Physiologic | 1 | 2016 | 173 | 0.030 |
Why?
| Absorptiometry, Photon | 1 | 2015 | 223 | 0.030 |
Why?
| Genes, Transgenic, Suicide | 1 | 2014 | 7 | 0.030 |
Why?
| Binding Sites | 1 | 1997 | 1173 | 0.030 |
Why?
| Trans-Activators | 1 | 1997 | 368 | 0.030 |
Why?
| Protein-Tyrosine Kinases | 1 | 1997 | 396 | 0.030 |
Why?
| Cellular Microenvironment | 1 | 2015 | 78 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 1997 | 616 | 0.030 |
Why?
| Ovary | 1 | 2015 | 191 | 0.030 |
Why?
| Chromosome Mapping | 1 | 1995 | 490 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 315 | 0.030 |
Why?
| Anions | 1 | 2013 | 30 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2015 | 370 | 0.030 |
Why?
| Chromatography, Liquid | 1 | 2015 | 348 | 0.030 |
Why?
| Molecular Conformation | 1 | 2013 | 137 | 0.030 |
Why?
| Fatty Acids | 1 | 2015 | 385 | 0.030 |
Why?
| Genetic Therapy | 1 | 2014 | 258 | 0.030 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 2012 | 152 | 0.020 |
Why?
| Heterografts | 1 | 2012 | 117 | 0.020 |
Why?
| Gene Library | 1 | 2012 | 114 | 0.020 |
Why?
| Protein Binding | 1 | 1997 | 1898 | 0.020 |
Why?
| Male | 4 | 2017 | 55730 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2015 | 1138 | 0.020 |
Why?
| Nitriles | 1 | 2011 | 152 | 0.020 |
Why?
| Protein Kinases | 1 | 1992 | 307 | 0.020 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 799 | 0.020 |
Why?
| Triazoles | 1 | 2011 | 130 | 0.020 |
Why?
| Sequence Analysis, DNA | 1 | 2012 | 728 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2011 | 719 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2017 | 4411 | 0.020 |
Why?
| Transcriptome | 1 | 2012 | 725 | 0.020 |
Why?
| Receptors, Pituitary Hormone-Regulating Hormone | 1 | 2006 | 7 | 0.020 |
Why?
| Receptors, Neuropeptide | 1 | 2006 | 11 | 0.020 |
Why?
| Prognosis | 1 | 2012 | 3334 | 0.010 |
Why?
| Liver | 1 | 1992 | 1681 | 0.010 |
Why?
| Suppression, Genetic | 1 | 2003 | 23 | 0.010 |
Why?
| Genetic Vectors | 1 | 2004 | 291 | 0.010 |
Why?
| Genes, Dominant | 1 | 2003 | 94 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2012 | 3545 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2003 | 337 | 0.010 |
Why?
| Amino Acid Sequence | 2 | 1997 | 1990 | 0.010 |
Why?
| Phosphothreonine | 1 | 1997 | 6 | 0.010 |
Why?
| Sequence Alignment | 1 | 1997 | 325 | 0.010 |
Why?
| Sequence Homology, Amino Acid | 1 | 1997 | 353 | 0.010 |
Why?
| Structure-Activity Relationship | 1 | 1997 | 503 | 0.010 |
Why?
| Drosophila Proteins | 1 | 1997 | 163 | 0.010 |
Why?
| Nerve Tissue Proteins | 1 | 1997 | 529 | 0.010 |
Why?
| Biological Evolution | 1 | 1997 | 415 | 0.010 |
Why?
| Chromatography, Ion Exchange | 1 | 1992 | 48 | 0.010 |
Why?
| Chromatography, Gel | 1 | 1992 | 125 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1992 | 376 | 0.010 |
Why?
| Molecular Weight | 1 | 1992 | 331 | 0.010 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 317 | 0.010 |
Why?
| Peptides | 1 | 1997 | 849 | 0.010 |
Why?
| Cytosol | 1 | 1992 | 208 | 0.010 |
Why?
| Substrate Specificity | 1 | 1992 | 355 | 0.010 |
Why?
| Oligopeptides | 1 | 1992 | 234 | 0.010 |
Why?
| Cells, Cultured | 1 | 1997 | 3896 | 0.010 |
Why?
| Kinetics | 1 | 1992 | 1558 | 0.000 |
Why?
|
|
Bradford's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|